Shell Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,214
| Closed | -$151K | – | 1426 |
|
2022
Q3 | $151K | Sell |
2,214
-555
| -20% | -$37.9K | 0.01% | 1104 |
|
2022
Q2 | $88K | Buy |
2,769
+10
| +0.4% | +$318 | ﹤0.01% | 1306 |
|
2022
Q1 | $96K | Sell |
2,759
-416
| -13% | -$14.5K | ﹤0.01% | 1301 |
|
2021
Q4 | $93K | Sell |
3,175
-52
| -2% | -$1.52K | ﹤0.01% | 1332 |
|
2021
Q3 | $82K | Sell |
3,227
-130
| -4% | -$3.3K | ﹤0.01% | 1323 |
|
2021
Q2 | $118K | Hold |
3,357
| – | – | ﹤0.01% | 1334 |
|
2021
Q1 | $137K | Sell |
3,357
-944
| -22% | -$38.5K | ﹤0.01% | 1229 |
|
2020
Q4 | $186K | Hold |
4,301
| – | – | ﹤0.01% | 1137 |
|
2020
Q3 | $237K | Hold |
4,301
| – | – | 0.01% | 994 |
|
2020
Q2 | $272K | Sell |
4,301
-85
| -2% | -$5.38K | 0.01% | 934 |
|
2020
Q1 | $224K | Sell |
4,386
-67
| -2% | -$3.42K | 0.01% | 975 |
|
2019
Q4 | $354K | Sell |
4,453
-132
| -3% | -$10.5K | 0.01% | 1004 |
|
2019
Q3 | $222K | Sell |
4,585
-39
| -0.8% | -$1.89K | 0.01% | 1110 |
|
2019
Q2 | $243K | Sell |
4,624
-106
| -2% | -$5.57K | 0.01% | 1091 |
|
2019
Q1 | $250K | Buy |
+4,730
| New | +$250K | 0.01% | 1072 |
|